| # | Query | Results |
| S24 | S11 AND S23 | 61 |
| S23 | S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 | 1,301,554 |
| S22 | TX allocat* random* | 9,763 |
| S21 | (MH "Quantitative Studies") | 21,772 |
| S20 | (MH "Placebos") | 11,101 |
| S19 | TX placebo* | 55,070 |
| S18 | TX random* allocat* | 9,763 |
| S17 | (MH "Random Assignment") | 53,035 |
| S16 | TX randomi* control* trial* | 163,662 |
| S15 | TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) | 1,000,920 |
| S14 | TX clinic* n1 trial* | 238,474 |
| S13 | PT Clinical trial | 86,722 |
| S12 | (MH "Clinical Trials+") | 254,738 |
| S11 | S6 AND S10 | 165 |
| S10 | S7 OR S8 OR S9 | 10,573 |
| S9 | TX(progestagen* or progestational) | 2,226 |
| S8 | TX(Progestin* or progestogen* or progesterone or norethisterone or norethindrone or dydrogesterone or medroxyprogesterone) | 9,546 |
| S7 | (MM "Progestational Hormones+") | 2,192 |
| S6 | S1 OR S2 OR S3 OR S4 OR S5 | 1,606 |
| S5 | TX heavy N5 menstrua* | 460 |
| S4 | TX hypermenorrh* | 24 |
| S3 | TX (dysfunctional N5 uter*) | 134 |
| S2 | TX menorrhag* | 1,284 |
| S1 | (MM "Menorrhagia") | 691 |